

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.03727403 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.03727403 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.74543203 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.74543203 |
| 5 | exogenous drug catabolic process (GO:0042738) | 6.73111721 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.50821686 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.33138349 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.86561122 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.70912115 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.70912115 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.70912115 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 5.68653581 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.65807274 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.63896838 |
| 15 | omega-hydroxylase P450 pathway (GO:0097267) | 5.61719875 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.50526573 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.40608638 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.22951991 |
| 19 | cysteine metabolic process (GO:0006534) | 5.19735704 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.17781793 |
| 21 | urea cycle (GO:0000050) | 5.15815536 |
| 22 | urea metabolic process (GO:0019627) | 5.15815536 |
| 23 | lysine metabolic process (GO:0006553) | 5.11623227 |
| 24 | lysine catabolic process (GO:0006554) | 5.11623227 |
| 25 | blood coagulation, intrinsic pathway (GO:0007597) | 5.05211241 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.94908819 |
| 27 | serine family amino acid catabolic process (GO:0009071) | 4.86684041 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 4.86621588 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.84803893 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 4.82855971 |
| 31 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.80110581 |
| 32 | amino-acid betaine metabolic process (GO:0006577) | 4.79917108 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.78811810 |
| 34 | protein carboxylation (GO:0018214) | 4.78473643 |
| 35 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.78473643 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 4.75637492 |
| 37 | bile acid metabolic process (GO:0008206) | 4.74791609 |
| 38 | regulation of protein activation cascade (GO:2000257) | 4.70753611 |
| 39 | drug metabolic process (GO:0017144) | 4.69757169 |
| 40 | regulation of fibrinolysis (GO:0051917) | 4.67312515 |
| 41 | fibrinolysis (GO:0042730) | 4.62264382 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 4.60382599 |
| 43 | cellular ketone body metabolic process (GO:0046950) | 4.56990650 |
| 44 | regulation of plasminogen activation (GO:0010755) | 4.55321659 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 4.50011809 |
| 46 | acylglycerol homeostasis (GO:0055090) | 4.46239202 |
| 47 | triglyceride homeostasis (GO:0070328) | 4.46239202 |
| 48 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.44780139 |
| 49 | ethanol metabolic process (GO:0006067) | 4.42924179 |
| 50 | tyrosine metabolic process (GO:0006570) | 4.42348351 |
| 51 | regulation of complement activation (GO:0030449) | 4.40447514 |
| 52 | reverse cholesterol transport (GO:0043691) | 4.38935798 |
| 53 | negative regulation of protein activation cascade (GO:2000258) | 4.36742732 |
| 54 | regulation of cholesterol esterification (GO:0010872) | 4.35060522 |
| 55 | protein-lipid complex remodeling (GO:0034368) | 4.33006296 |
| 56 | macromolecular complex remodeling (GO:0034367) | 4.33006296 |
| 57 | plasma lipoprotein particle remodeling (GO:0034369) | 4.33006296 |
| 58 | protein-lipid complex assembly (GO:0065005) | 4.25561151 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 4.21413416 |
| 60 | cellular amino acid catabolic process (GO:0009063) | 4.21148072 |
| 61 | phospholipid efflux (GO:0033700) | 4.17674652 |
| 62 | negative regulation of cholesterol transport (GO:0032375) | 4.16376148 |
| 63 | negative regulation of sterol transport (GO:0032372) | 4.16376148 |
| 64 | short-chain fatty acid metabolic process (GO:0046459) | 4.16159042 |
| 65 | ethanol oxidation (GO:0006069) | 4.13286273 |
| 66 | acetyl-CoA metabolic process (GO:0006084) | 4.11532386 |
| 67 | intestinal cholesterol absorption (GO:0030299) | 4.09921753 |
| 68 | oxidative demethylation (GO:0070989) | 4.09184480 |
| 69 | coenzyme catabolic process (GO:0009109) | 4.09147146 |
| 70 | * fatty acid beta-oxidation (GO:0006635) | 4.07450695 |
| 71 | bile acid and bile salt transport (GO:0015721) | 4.05230580 |
| 72 | indolalkylamine metabolic process (GO:0006586) | 4.04802391 |
| 73 | protein activation cascade (GO:0072376) | 4.04339612 |
| 74 | cellular glucuronidation (GO:0052695) | 4.00741850 |
| 75 | glutamate metabolic process (GO:0006536) | 3.99499178 |
| 76 | glycine metabolic process (GO:0006544) | 3.98222879 |
| 77 | plasma lipoprotein particle organization (GO:0071827) | 3.97105062 |
| 78 | * fatty acid oxidation (GO:0019395) | 3.95728373 |
| 79 | ketone body metabolic process (GO:1902224) | 3.95727177 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 3.95439526 |
| 81 | 2-oxoglutarate metabolic process (GO:0006103) | 3.94198767 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 3.93460059 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 3.92881763 |
| 84 | phenylpropanoid metabolic process (GO:0009698) | 3.92342738 |
| 85 | cellular biogenic amine catabolic process (GO:0042402) | 3.90450204 |
| 86 | amine catabolic process (GO:0009310) | 3.90450204 |
| 87 | * lipid oxidation (GO:0034440) | 3.88220934 |
| 88 | drug catabolic process (GO:0042737) | 3.88038711 |
| 89 | * carboxylic acid catabolic process (GO:0046395) | 3.86323527 |
| 90 | * organic acid catabolic process (GO:0016054) | 3.86323527 |
| 91 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.85499066 |
| 92 | regulation of humoral immune response (GO:0002920) | 3.85404531 |
| 93 | aspartate family amino acid catabolic process (GO:0009068) | 3.85268549 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 3.84692794 |
| 95 | * fatty acid catabolic process (GO:0009062) | 3.83664610 |
| 96 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.83649678 |
| 97 | phospholipid homeostasis (GO:0055091) | 3.83233385 |
| 98 | * monocarboxylic acid catabolic process (GO:0072329) | 3.82742952 |
| 99 | cholesterol efflux (GO:0033344) | 3.80350109 |
| 100 | carnitine metabolic process (GO:0009437) | 3.79478177 |
| 101 | protein-lipid complex subunit organization (GO:0071825) | 3.77936675 |
| 102 | imidazole-containing compound metabolic process (GO:0052803) | 3.77010491 |
| 103 | negative regulation of blood coagulation (GO:0030195) | 3.73042646 |
| 104 | negative regulation of hemostasis (GO:1900047) | 3.73042646 |
| 105 | valine metabolic process (GO:0006573) | 3.70728234 |
| 106 | serine family amino acid biosynthetic process (GO:0009070) | 3.68669204 |
| 107 | complement activation, classical pathway (GO:0006958) | 3.67293412 |
| 108 | S-adenosylmethionine metabolic process (GO:0046500) | 3.65752770 |
| 109 | plasma lipoprotein particle assembly (GO:0034377) | 3.65238077 |
| 110 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.61943026 |
| 111 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.61943026 |
| 112 | arginine metabolic process (GO:0006525) | 3.61549938 |
| 113 | negative regulation of lipase activity (GO:0060192) | 3.61199835 |
| 114 | drug transmembrane transport (GO:0006855) | 3.61086916 |
| 115 | cholesterol homeostasis (GO:0042632) | 3.60673488 |
| 116 | complement activation (GO:0006956) | 3.59913306 |
| 117 | regulation of bile acid biosynthetic process (GO:0070857) | 3.58613521 |
| 118 | regulation of cholesterol homeostasis (GO:2000188) | 3.57458844 |
| 119 | low-density lipoprotein particle remodeling (GO:0034374) | 3.56945798 |
| 120 | uronic acid metabolic process (GO:0006063) | 3.56250252 |
| 121 | glucuronate metabolic process (GO:0019585) | 3.56250252 |
| 122 | aldehyde catabolic process (GO:0046185) | 3.55842415 |
| 123 | sterol homeostasis (GO:0055092) | 3.55414102 |
| 124 | fatty acid transmembrane transport (GO:1902001) | 3.54598632 |
| 125 | regulation of apoptotic cell clearance (GO:2000425) | 3.50131819 |
| 126 | acute-phase response (GO:0006953) | 3.43500374 |
| 127 | lipoprotein metabolic process (GO:0042157) | 3.40882435 |
| 128 | negative regulation of coagulation (GO:0050819) | 3.40413874 |
| 129 | negative regulation of wound healing (GO:0061045) | 3.36507240 |
| 130 | negative regulation of complement activation (GO:0045916) | 3.29230143 |
| 131 | positive regulation of blood coagulation (GO:0030194) | 3.27960084 |
| 132 | positive regulation of hemostasis (GO:1900048) | 3.27960084 |
| 133 | polyketide metabolic process (GO:0030638) | 3.27604516 |
| 134 | doxorubicin metabolic process (GO:0044598) | 3.27604516 |
| 135 | daunorubicin metabolic process (GO:0044597) | 3.27604516 |
| 136 | regulation of cholesterol metabolic process (GO:0090181) | 3.20460155 |
| 137 | lipoprotein transport (GO:0042953) | 3.20215377 |
| 138 | sterol transport (GO:0015918) | 3.12166509 |
| 139 | cholesterol transport (GO:0030301) | 3.12166509 |
| 140 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.11934680 |
| 141 | response to mercury ion (GO:0046689) | 3.11514677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.94456526 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.86610407 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.33378329 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.26392102 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.09399188 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.04756983 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.52811362 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.99757497 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.52012495 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.09641247 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.71508087 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.29667682 |
| 13 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.15447745 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.10068052 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03937705 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.02214941 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1462350 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86287747 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.66259218 |
| 20 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64889627 |
| 21 | TP53_16413492_ChIP-PET_HCT116_Human | 1.63481436 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63148906 |
| 23 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.62159325 |
| 24 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.56739672 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.44903799 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.42132975 |
| 27 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40451842 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39990851 |
| 29 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.39013086 |
| 30 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.37285809 |
| 31 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.33005272 |
| 32 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.30246739 |
| 33 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.29852618 |
| 34 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26012659 |
| 35 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.24894073 |
| 36 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.24725315 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19151434 |
| 38 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.18105287 |
| 39 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17264153 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14103421 |
| 41 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.12804062 |
| 42 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11471072 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10722237 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10109301 |
| 45 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05656605 |
| 46 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05306942 |
| 47 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05114712 |
| 48 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04901636 |
| 49 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.04901079 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04079472 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03819202 |
| 52 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01174520 |
| 53 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98768769 |
| 54 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.97846277 |
| 55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.97764922 |
| 56 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95796842 |
| 57 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.95244316 |
| 58 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94056676 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93925685 |
| 60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92273795 |
| 61 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91494769 |
| 62 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89116095 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87671693 |
| 64 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87442811 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.85344768 |
| 66 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84186865 |
| 67 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83410068 |
| 68 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.83311643 |
| 69 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82326627 |
| 70 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82274647 |
| 71 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.80753198 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79629335 |
| 73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79035259 |
| 74 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78414794 |
| 75 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.78275753 |
| 76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.77916033 |
| 77 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.76253548 |
| 78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76186128 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76186128 |
| 80 | P300_19829295_ChIP-Seq_ESCs_Human | 0.76175827 |
| 81 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.75598656 |
| 82 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.75000626 |
| 83 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74684222 |
| 84 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74573796 |
| 85 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.74393805 |
| 86 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74074137 |
| 87 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73422265 |
| 88 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.73383371 |
| 89 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.72487968 |
| 90 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.72343406 |
| 91 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.72230487 |
| 92 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.72230487 |
| 93 | CJUN_26792858_Chip-Seq_BT549_Human | 0.71997152 |
| 94 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.71632234 |
| 95 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.71136204 |
| 96 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.70347206 |
| 97 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.69960399 |
| 98 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.69907691 |
| 99 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.69361474 |
| 100 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.69316905 |
| 101 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.69031112 |
| 102 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.68963206 |
| 103 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.68188775 |
| 104 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67689768 |
| 105 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.67657724 |
| 106 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.67581443 |
| 107 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.67244471 |
| 108 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65869742 |
| 109 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64736811 |
| 110 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64333392 |
| 111 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64062940 |
| 112 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.63571720 |
| 113 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62900927 |
| 114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62809850 |
| 115 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.62447024 |
| 116 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.62447024 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.62109294 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61369780 |
| 119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.60830243 |
| 120 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.59406270 |
| 121 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.59205519 |
| 122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.58610902 |
| 123 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.57937621 |
| 124 | CBP_21632823_ChIP-Seq_H3396_Human | 0.55267176 |
| 125 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54667538 |
| 126 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53817233 |
| 127 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.52558607 |
| 128 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52009474 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.51942189 |
| 130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.51693396 |
| 131 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.51266973 |
| 132 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.50556073 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.50552013 |
| 134 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.50339892 |
| 135 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48240056 |
| 136 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.48221708 |
| 137 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.47952757 |
| 138 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.47654402 |
| 139 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.46326854 |
| 140 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45742434 |
| 141 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.45619260 |
| 142 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.45488275 |
| 143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.45197238 |
| 144 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.44648158 |
| 145 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.44251842 |
| 146 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.43815188 |
| 147 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43102850 |
| 148 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.42470813 |
| 149 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.41415533 |
| 150 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.41070621 |
| 151 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.39797421 |
| 152 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.39150981 |
| 153 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38378750 |
| 154 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.37683792 |
| 155 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37532882 |
| 156 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.37354655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.88319629 |
| 2 | MP0005360_urolithiasis | 7.23103705 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.04748529 |
| 4 | MP0005365_abnormal_bile_salt | 5.94037999 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.88677967 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.07073291 |
| 7 | MP0003252_abnormal_bile_duct | 3.78747911 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.55888277 |
| 9 | MP0009840_abnormal_foam_cell | 2.99151841 |
| 10 | MP0005332_abnormal_amino_acid | 2.90164603 |
| 11 | MP0003195_calcinosis | 2.80901248 |
| 12 | MP0005083_abnormal_biliary_tract | 2.78206373 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.57333292 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.34666257 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.25101744 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.22429810 |
| 17 | MP0004272_abnormal_basement_membrane | 2.19532090 |
| 18 | MP0000609_abnormal_liver_physiology | 2.13167290 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.93477420 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.86066021 |
| 21 | MP0005670_abnormal_white_adipose | 1.75420788 |
| 22 | MP0003868_abnormal_feces_composition | 1.69054623 |
| 23 | MP0001764_abnormal_homeostasis | 1.63997103 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.62568145 |
| 25 | MP0005451_abnormal_body_composition | 1.56753765 |
| 26 | MP0003122_maternal_imprinting | 1.49043882 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.48414645 |
| 28 | MP0002837_dystrophic_cardiac_calcinosis | 1.46528832 |
| 29 | MP0004130_abnormal_muscle_cell | 1.42692695 |
| 30 | MP0003186_abnormal_redox_activity | 1.38641753 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.38090491 |
| 32 | MP0009697_abnormal_copulation | 1.31849719 |
| 33 | MP0005503_abnormal_tendon_morphology | 1.28030885 |
| 34 | MP0000566_synostosis | 1.27575430 |
| 35 | MP0001984_abnormal_olfaction | 1.26155694 |
| 36 | MP0003011_delayed_dark_adaptation | 1.24684734 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.20184041 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.17141473 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.13855259 |
| 40 | MP0005666_abnormal_adipose_tissue | 1.11873475 |
| 41 | MP0000598_abnormal_liver_morphology | 1.09759049 |
| 42 | MP0002971_abnormal_brown_adipose | 1.06557469 |
| 43 | MP0005647_abnormal_sex_gland | 1.05093186 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.05060247 |
| 45 | MP0002254_reproductive_system_inflammat | 1.04515574 |
| 46 | MP0001986_abnormal_taste_sensitivity | 1.02647849 |
| 47 | MP0002132_abnormal_respiratory_system | 1.02203729 |
| 48 | MP0002876_abnormal_thyroid_physiology | 1.02167854 |
| 49 | MP0005636_abnormal_mineral_homeostasis | 1.00750874 |
| 50 | MP0009764_decreased_sensitivity_to | 0.97086792 |
| 51 | MP0002078_abnormal_glucose_homeostasis | 0.95623058 |
| 52 | MP0009763_increased_sensitivity_to | 0.95550944 |
| 53 | MP0003879_abnormal_hair_cell | 0.94787607 |
| 54 | MP0005334_abnormal_fat_pad | 0.90819241 |
| 55 | MP0005535_abnormal_body_temperature | 0.90769522 |
| 56 | MP0001915_intracranial_hemorrhage | 0.89149356 |
| 57 | MP0000604_amyloidosis | 0.89134009 |
| 58 | MP0010368_abnormal_lymphatic_system | 0.87152130 |
| 59 | MP0009642_abnormal_blood_homeostasis | 0.86920149 |
| 60 | MP0001661_extended_life_span | 0.85354743 |
| 61 | MP0001756_abnormal_urination | 0.83310242 |
| 62 | MP0004043_abnormal_pH_regulation | 0.82433955 |
| 63 | MP0002282_abnormal_trachea_morphology | 0.81740150 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 0.81267871 |
| 65 | MP0002295_abnormal_pulmonary_circulatio | 0.80956229 |
| 66 | MP0008469_abnormal_protein_level | 0.80585264 |
| 67 | MP0005376_homeostasis/metabolism_phenot | 0.79413567 |
| 68 | MP0004084_abnormal_cardiac_muscle | 0.78045420 |
| 69 | MP0008775_abnormal_heart_ventricle | 0.77176098 |
| 70 | MP0005266_abnormal_metabolism | 0.76450432 |
| 71 | MP0005187_abnormal_penis_morphology | 0.75076670 |
| 72 | MP0003690_abnormal_glial_cell | 0.73355935 |
| 73 | MP0005408_hypopigmentation | 0.70659799 |
| 74 | MP0001270_distended_abdomen | 0.70443429 |
| 75 | MP0006035_abnormal_mitochondrial_morpho | 0.69113756 |
| 76 | MP0005448_abnormal_energy_balance | 0.68199947 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 0.68020001 |
| 78 | MP0005220_abnormal_exocrine_pancreas | 0.65412577 |
| 79 | MP0005023_abnormal_wound_healing | 0.65235661 |
| 80 | MP0003950_abnormal_plasma_membrane | 0.65124204 |
| 81 | MP0000751_myopathy | 0.63185234 |
| 82 | MP0002136_abnormal_kidney_physiology | 0.61698654 |
| 83 | MP0003646_muscle_fatigue | 0.60941979 |
| 84 | MP0004185_abnormal_adipocyte_glucose | 0.60533310 |
| 85 | MP0001299_abnormal_eye_distance/ | 0.58909340 |
| 86 | MP0005330_cardiomyopathy | 0.58272425 |
| 87 | MP0002233_abnormal_nose_morphology | 0.57565796 |
| 88 | MP0005164_abnormal_response_to | 0.57384464 |
| 89 | MP0009115_abnormal_fat_cell | 0.57000613 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.56918120 |
| 91 | MP0008789_abnormal_olfactory_epithelium | 0.56659598 |
| 92 | MP0000013_abnormal_adipose_tissue | 0.56486676 |
| 93 | MP0005375_adipose_tissue_phenotype | 0.56067333 |
| 94 | MP0002128_abnormal_blood_circulation | 0.55849968 |
| 95 | MP0002697_abnormal_eye_size | 0.54922665 |
| 96 | MP0002249_abnormal_larynx_morphology | 0.54444316 |
| 97 | MP0002822_catalepsy | 0.53573704 |
| 98 | MP0000230_abnormal_systemic_arterial | 0.53488302 |
| 99 | MP0003329_amyloid_beta_deposits | 0.53216842 |
| 100 | MP0001293_anophthalmia | 0.53033005 |
| 101 | MP0003953_abnormal_hormone_level | 0.51015119 |
| 102 | MP0006054_spinal_hemorrhage | 0.50684975 |
| 103 | MP0003718_maternal_effect | 0.49580889 |
| 104 | MP0004215_abnormal_myocardial_fiber | 0.48280266 |
| 105 | MP0009379_abnormal_foot_pigmentation | 0.47641789 |
| 106 | MP0002970_abnormal_white_adipose | 0.47538161 |
| 107 | MP0003724_increased_susceptibility_to | 0.47536012 |
| 108 | MP0010030_abnormal_orbit_morphology | 0.47447302 |
| 109 | MP0002108_abnormal_muscle_morphology | 0.46469516 |
| 110 | MP0002928_abnormal_bile_duct | 0.46148941 |
| 111 | MP0002796_impaired_skin_barrier | 0.46135443 |
| 112 | MP0004036_abnormal_muscle_relaxation | 0.45739599 |
| 113 | MP0002234_abnormal_pharynx_morphology | 0.45007163 |
| 114 | MP0002269_muscular_atrophy | 0.44863226 |
| 115 | MP0003279_aneurysm | 0.44765343 |
| 116 | MP0005395_other_phenotype | 0.43816025 |
| 117 | MP0000003_abnormal_adipose_tissue | 0.43265481 |
| 118 | MP0001765_abnormal_ion_homeostasis | 0.42474517 |
| 119 | MP0000639_abnormal_adrenal_gland | 0.42013229 |
| 120 | MP0003638_abnormal_response/metabolism_ | 0.41558896 |
| 121 | MP0008874_decreased_physiological_sensi | 0.40819944 |
| 122 | MP0004782_abnormal_surfactant_physiolog | 0.37867650 |
| 123 | MP0002168_other_aberrant_phenotype | 0.37774879 |
| 124 | MP0005058_abnormal_lysosome_morphology | 0.37465323 |
| 125 | MP0009053_abnormal_anal_canal | 0.36792671 |
| 126 | MP0008873_increased_physiological_sensi | 0.36322914 |
| 127 | MP0003959_abnormal_lean_body | 0.36211926 |
| 128 | MP0009672_abnormal_birth_weight | 0.35851474 |
| 129 | MP0009384_cardiac_valve_regurgitation | 0.34415417 |
| 130 | MP0001853_heart_inflammation | 0.34228074 |
| 131 | MP0003075_altered_response_to | 0.33569936 |
| 132 | MP0008872_abnormal_physiological_respon | 0.33260044 |
| 133 | MP0005167_abnormal_blood-brain_barrier | 0.32924621 |
| 134 | MP0005464_abnormal_platelet_physiology | 0.32135553 |
| 135 | MP0006138_congestive_heart_failure | 0.31818622 |
| 136 | MP0000249_abnormal_blood_vessel | 0.31083937 |
| 137 | MP0002060_abnormal_skin_morphology | 0.30414522 |
| 138 | MP0005166_decreased_susceptibility_to | 0.30407122 |
| 139 | MP0001881_abnormal_mammary_gland | 0.29640698 |
| 140 | MP0000579_abnormal_nail_morphology | 0.28898793 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.63726390 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.57510600 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.41529758 |
| 4 | Xanthomatosis (HP:0000991) | 5.94857124 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.86044841 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.66827748 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.63943727 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.11753649 |
| 9 | Hyperammonemia (HP:0001987) | 4.83780498 |
| 10 | Complement deficiency (HP:0004431) | 4.72128643 |
| 11 | Hyperglycinuria (HP:0003108) | 4.67309549 |
| 12 | Ketosis (HP:0001946) | 4.67069316 |
| 13 | Hyperglycinemia (HP:0002154) | 4.51840130 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.51182356 |
| 15 | Hypoglycemic coma (HP:0001325) | 4.45318443 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 4.43760425 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.43760425 |
| 18 | Epidermoid cyst (HP:0200040) | 4.36178163 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.24093083 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.18454139 |
| 21 | Joint hemorrhage (HP:0005261) | 4.18147031 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.15277082 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.10745962 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.04678502 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.95912644 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 3.90775923 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.87836009 |
| 28 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.82505489 |
| 29 | Ketoacidosis (HP:0001993) | 3.75451381 |
| 30 | Fat malabsorption (HP:0002630) | 3.74583355 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.42437443 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.38646600 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.38034411 |
| 34 | Abnormality of complement system (HP:0005339) | 3.36585506 |
| 35 | Dicarboxylic aciduria (HP:0003215) | 3.24592679 |
| 36 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.24592679 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.23674429 |
| 38 | Nephritis (HP:0000123) | 3.20166600 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.16537712 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.13535690 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.08780522 |
| 42 | Delayed CNS myelination (HP:0002188) | 3.08764154 |
| 43 | Metabolic acidosis (HP:0001942) | 3.07416426 |
| 44 | Abnormality of purine metabolism (HP:0004352) | 3.01333569 |
| 45 | Gout (HP:0001997) | 2.88496634 |
| 46 | Lethargy (HP:0001254) | 2.87140026 |
| 47 | Skin nodule (HP:0200036) | 2.81698315 |
| 48 | Gingival bleeding (HP:0000225) | 2.78657898 |
| 49 | Generalized aminoaciduria (HP:0002909) | 2.73923846 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 2.73116455 |
| 51 | Cerebral edema (HP:0002181) | 2.72692145 |
| 52 | Steatorrhea (HP:0002570) | 2.72314598 |
| 53 | Hypoglycemic seizures (HP:0002173) | 2.67771574 |
| 54 | Myocardial infarction (HP:0001658) | 2.66014236 |
| 55 | Osteomalacia (HP:0002749) | 2.61317645 |
| 56 | Spontaneous abortion (HP:0005268) | 2.56593787 |
| 57 | Vascular calcification (HP:0004934) | 2.52486230 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.41741183 |
| 59 | Systemic lupus erythematosus (HP:0002725) | 2.39952186 |
| 60 | Proximal tubulopathy (HP:0000114) | 2.39357564 |
| 61 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.38591909 |
| 62 | Vomiting (HP:0002013) | 2.36690609 |
| 63 | Cholelithiasis (HP:0001081) | 2.36267572 |
| 64 | Hypochromic microcytic anemia (HP:0004840) | 2.36172028 |
| 65 | Renal cortical cysts (HP:0000803) | 2.34702843 |
| 66 | Acanthocytosis (HP:0001927) | 2.29646401 |
| 67 | Abnormality of proline metabolism (HP:0010907) | 2.29248162 |
| 68 | Hydroxyprolinuria (HP:0003080) | 2.29248162 |
| 69 | Protrusio acetabuli (HP:0003179) | 2.28695746 |
| 70 | Malnutrition (HP:0004395) | 2.28495504 |
| 71 | Chronic hepatic failure (HP:0100626) | 2.27738567 |
| 72 | Pancreatitis (HP:0001733) | 2.27166748 |
| 73 | Irritability (HP:0000737) | 2.26546445 |
| 74 | Spastic diplegia (HP:0001264) | 2.25712893 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.25266148 |
| 76 | Late onset (HP:0003584) | 2.21968884 |
| 77 | Myoglobinuria (HP:0002913) | 2.21848337 |
| 78 | Neonatal onset (HP:0003623) | 2.21581271 |
| 79 | Hyperuricemia (HP:0002149) | 2.19755225 |
| 80 | Increased purine levels (HP:0004368) | 2.19755225 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.18244426 |
| 82 | Abnormal delivery (HP:0001787) | 2.17613464 |
| 83 | Enlarged kidneys (HP:0000105) | 2.17409148 |
| 84 | Arthropathy (HP:0003040) | 2.16398826 |
| 85 | Hyperphosphaturia (HP:0003109) | 2.13874955 |
| 86 | Brushfield spots (HP:0001088) | 2.12604997 |
| 87 | Facial shape deformation (HP:0011334) | 2.12087874 |
| 88 | Potter facies (HP:0002009) | 2.12087874 |
| 89 | Cholecystitis (HP:0001082) | 2.10689459 |
| 90 | Abnormal gallbladder physiology (HP:0012438) | 2.10689459 |
| 91 | Abnormality of urine glucose concentration (HP:0011016) | 2.08328820 |
| 92 | Glycosuria (HP:0003076) | 2.08328820 |
| 93 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.07811347 |
| 94 | Hyperglycemia (HP:0003074) | 2.07264553 |
| 95 | Esophageal varix (HP:0002040) | 2.04946940 |
| 96 | Mitral stenosis (HP:0001718) | 2.03107771 |
| 97 | Alkalosis (HP:0001948) | 2.03031331 |
| 98 | Abnormal cartilage morphology (HP:0002763) | 2.00572987 |
| 99 | Glomerulonephritis (HP:0000099) | 1.99007141 |
| 100 | Hemorrhage of the eye (HP:0011885) | 1.97100937 |
| 101 | Nausea (HP:0002018) | 1.96428624 |
| 102 | Abnormal biliary tract physiology (HP:0012439) | 1.95227160 |
| 103 | Bile duct proliferation (HP:0001408) | 1.95227160 |
| 104 | Abnormal tarsal ossification (HP:0008369) | 1.94953902 |
| 105 | Amyloidosis (HP:0011034) | 1.94440785 |
| 106 | Opisthotonus (HP:0002179) | 1.93788965 |
| 107 | Abnormality of the gallbladder (HP:0005264) | 1.92873228 |
| 108 | Hypertriglyceridemia (HP:0002155) | 1.92828294 |
| 109 | Rickets (HP:0002748) | 1.89650891 |
| 110 | Abnormality of carpal bone ossification (HP:0006257) | 1.89293529 |
| 111 | Elevated hepatic transaminases (HP:0002910) | 1.84579077 |
| 112 | Retinal atrophy (HP:0001105) | 1.84134651 |
| 113 | Symptomatic seizures (HP:0011145) | 1.83179303 |
| 114 | Increased serum pyruvate (HP:0003542) | 1.81315457 |
| 115 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80730495 |
| 116 | Thrombophlebitis (HP:0004418) | 1.80479931 |
| 117 | Abnormality of vitamin metabolism (HP:0100508) | 1.80108071 |
| 118 | Hypophosphatemic rickets (HP:0004912) | 1.79796055 |
| 119 | Abnormal urine phosphate concentration (HP:0012599) | 1.79244500 |
| 120 | Type II lissencephaly (HP:0007260) | 1.79069825 |
| 121 | Broad alveolar ridges (HP:0000187) | 1.77141607 |
| 122 | Menorrhagia (HP:0000132) | 1.76934489 |
| 123 | Bifid scrotum (HP:0000048) | 1.75864240 |
| 124 | Calf muscle hypertrophy (HP:0008981) | 1.67982044 |
| 125 | Fair hair (HP:0002286) | 1.57133519 |
| 126 | Flat acetabular roof (HP:0003180) | 1.57009932 |
| 127 | Cervical subluxation (HP:0003308) | 1.54327124 |
| 128 | Broad palm (HP:0001169) | 1.53378920 |
| 129 | Joint swelling (HP:0001386) | 1.52256103 |
| 130 | Hepatoblastoma (HP:0002884) | 1.48106507 |
| 131 | Elevated alkaline phosphatase (HP:0003155) | 1.46373009 |
| 132 | Abnormal hand bone ossification (HP:0010660) | 1.44140578 |
| 133 | Retinal dysplasia (HP:0007973) | 1.44038635 |
| 134 | Pigmentary retinal degeneration (HP:0001146) | 1.43580204 |
| 135 | Abnormality of the vitreous humor (HP:0004327) | 1.41944664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.25125431 |
| 2 | SIK1 | 3.98315655 |
| 3 | FGFR4 | 3.54060386 |
| 4 | ERN1 | 3.47461104 |
| 5 | INSRR | 3.34336012 |
| 6 | MST1R | 2.71004730 |
| 7 | TRIB3 | 2.34361073 |
| 8 | PDGFRA | 2.26965606 |
| 9 | TAOK3 | 2.20226668 |
| 10 | PKN2 | 2.17601247 |
| 11 | ERBB4 | 2.11492738 |
| 12 | CAMKK2 | 1.91503697 |
| 13 | MAP3K13 | 1.88547125 |
| 14 | PDK4 | 1.88393088 |
| 15 | PDK3 | 1.88393088 |
| 16 | LATS1 | 1.87714817 |
| 17 | MAP2K4 | 1.78013530 |
| 18 | PINK1 | 1.75751549 |
| 19 | PIK3CG | 1.71081386 |
| 20 | FRK | 1.69683638 |
| 21 | FLT3 | 1.69298816 |
| 22 | MAPK11 | 1.61032942 |
| 23 | CDK19 | 1.57055020 |
| 24 | DDR2 | 1.55679437 |
| 25 | PRKAA2 | 1.45079733 |
| 26 | CAMK1D | 1.44445822 |
| 27 | BRSK2 | 1.44120794 |
| 28 | STK38L | 1.43213848 |
| 29 | PTK6 | 1.40652621 |
| 30 | NTRK1 | 1.39126635 |
| 31 | TIE1 | 1.38559381 |
| 32 | MAP3K7 | 1.30114913 |
| 33 | NEK9 | 1.28956485 |
| 34 | NLK | 1.26281899 |
| 35 | TYK2 | 1.25764517 |
| 36 | BRD4 | 1.22158414 |
| 37 | AKT3 | 1.15192717 |
| 38 | TYRO3 | 1.15088976 |
| 39 | CDC42BPA | 1.14618617 |
| 40 | PDK2 | 1.14397511 |
| 41 | PIK3CA | 1.14288897 |
| 42 | ABL2 | 1.13485692 |
| 43 | BCR | 1.13398682 |
| 44 | MET | 1.13244669 |
| 45 | SCYL2 | 1.12999983 |
| 46 | FGFR2 | 1.12612661 |
| 47 | NTRK3 | 1.11595213 |
| 48 | PBK | 1.11031371 |
| 49 | JAK2 | 1.05863366 |
| 50 | MAP3K3 | 1.04998128 |
| 51 | WNK4 | 1.02114834 |
| 52 | MARK1 | 1.02111448 |
| 53 | MAP2K3 | 1.01605071 |
| 54 | KDR | 0.99022408 |
| 55 | RIPK1 | 0.98739296 |
| 56 | PRKAA1 | 0.94169356 |
| 57 | JAK1 | 0.93947758 |
| 58 | NTRK2 | 0.93516109 |
| 59 | DAPK2 | 0.93244864 |
| 60 | EPHA4 | 0.93235707 |
| 61 | LMTK2 | 0.91739857 |
| 62 | IRAK3 | 0.91220444 |
| 63 | EPHB1 | 0.90263190 |
| 64 | TTN | 0.87435036 |
| 65 | MARK2 | 0.82970296 |
| 66 | MYLK | 0.82552283 |
| 67 | TGFBR2 | 0.82138154 |
| 68 | OBSCN | 0.80509131 |
| 69 | FER | 0.79763115 |
| 70 | CSNK1A1L | 0.79424184 |
| 71 | CAMK1G | 0.78098309 |
| 72 | PRKACG | 0.77627450 |
| 73 | SGK3 | 0.76455207 |
| 74 | SRPK1 | 0.75515950 |
| 75 | CSNK1G1 | 0.74203798 |
| 76 | MAPK12 | 0.73632183 |
| 77 | TBK1 | 0.73608728 |
| 78 | PRKG1 | 0.72471559 |
| 79 | PRKCG | 0.71673613 |
| 80 | MAPK4 | 0.71498878 |
| 81 | EEF2K | 0.71189676 |
| 82 | PDGFRB | 0.70893976 |
| 83 | DYRK1A | 0.70258027 |
| 84 | ERBB3 | 0.69376524 |
| 85 | ERBB2 | 0.67931913 |
| 86 | PDPK1 | 0.67833501 |
| 87 | EPHB2 | 0.66596587 |
| 88 | CAMK1 | 0.66335355 |
| 89 | STK39 | 0.66224955 |
| 90 | WNK1 | 0.65401285 |
| 91 | CDK9 | 0.64846470 |
| 92 | GSK3A | 0.64070993 |
| 93 | SGK2 | 0.63780708 |
| 94 | MAP3K14 | 0.63041834 |
| 95 | WNK3 | 0.62630777 |
| 96 | NEK6 | 0.62289654 |
| 97 | EPHA3 | 0.62070080 |
| 98 | CDK6 | 0.61815856 |
| 99 | MAPKAPK3 | 0.61492069 |
| 100 | KSR2 | 0.61090508 |
| 101 | EIF2AK3 | 0.59917320 |
| 102 | PRKACB | 0.59664687 |
| 103 | PRKCZ | 0.59504450 |
| 104 | PHKG2 | 0.59164883 |
| 105 | PHKG1 | 0.59164883 |
| 106 | GRK6 | 0.59010100 |
| 107 | CSNK1G3 | 0.58933952 |
| 108 | CAMK2G | 0.58019920 |
| 109 | FGFR1 | 0.56897534 |
| 110 | SGK223 | 0.56004040 |
| 111 | SGK494 | 0.56004040 |
| 112 | MAP3K10 | 0.54352882 |
| 113 | FGFR3 | 0.53655325 |
| 114 | PRKACA | 0.52884404 |
| 115 | MAPK10 | 0.52058298 |
| 116 | MAPK15 | 0.51667530 |
| 117 | PTK2 | 0.51368642 |
| 118 | PRKCE | 0.51162653 |
| 119 | MAP2K1 | 0.50667264 |
| 120 | OXSR1 | 0.50575122 |
| 121 | RPS6KA3 | 0.50407710 |
| 122 | PAK3 | 0.49409093 |
| 123 | MAPK7 | 0.48840657 |
| 124 | MAP2K6 | 0.48795332 |
| 125 | STK3 | 0.48507807 |
| 126 | PDK1 | 0.48133750 |
| 127 | NEK1 | 0.47838062 |
| 128 | DYRK1B | 0.46747584 |
| 129 | UHMK1 | 0.46671264 |
| 130 | CSK | 0.46577232 |
| 131 | CASK | 0.46335394 |
| 132 | SRC | 0.45834083 |
| 133 | MAP3K5 | 0.44982597 |
| 134 | CSNK1D | 0.44397910 |
| 135 | CSNK1G2 | 0.43832054 |
| 136 | MAP3K2 | 0.43237784 |
| 137 | RET | 0.40536825 |
| 138 | MAP3K6 | 0.40032573 |
| 139 | IGF1R | 0.39984927 |
| 140 | PRKCQ | 0.36875912 |
| 141 | GRK1 | 0.36639803 |
| 142 | PKN1 | 0.35069116 |
| 143 | PRKD1 | 0.34849678 |
| 144 | MTOR | 0.34389360 |
| 145 | MAP3K11 | 0.33851087 |
| 146 | ICK | 0.33811336 |
| 147 | IKBKE | 0.30062329 |
| 148 | IRAK1 | 0.29482998 |
| 149 | MAP2K2 | 0.28991386 |
| 150 | CAMK4 | 0.27728583 |
| 151 | STK38 | 0.26262601 |
| 152 | CDK4 | 0.25447896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.04313599 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.29760553 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.16989599 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.14074214 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.87352647 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79631243 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.78624128 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.70662769 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67950664 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61661512 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.50264429 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.37249151 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.35197616 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.34917288 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18557782 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.17293842 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.17279820 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.10763201 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00761956 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.93246316 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87846508 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.78428614 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77185113 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.76309023 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75998675 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.69999761 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67805086 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64777304 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64161221 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58358986 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.56496312 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.54903870 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52682286 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52255790 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45424371 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45300788 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.45067562 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43310485 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.43262180 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.38566142 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36837180 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35338366 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.25721671 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24202101 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19568550 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.19455968 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19335451 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12638573 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99320283 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99163344 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98462744 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97034227 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95971760 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94788486 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92624734 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.89301249 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88657585 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87722870 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86124064 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85741799 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85699790 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82381303 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81382844 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81067996 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71013915 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58899502 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50299409 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49305643 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45316269 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39969477 |
| 71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.38574084 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37192552 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.36986110 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34830392 |
| 75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.34107749 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31128689 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21440992 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21403368 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20524732 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.19077521 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.17726429 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16267109 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14289651 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.09702411 |
| 85 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02249480 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | -0.2116925 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | -0.1868848 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1863058 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1683529 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1637197 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1624057 |
| 92 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1609836 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1585129 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1573535 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1561163 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1491774 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | -0.1417604 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1242661 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1214989 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1140851 |
| 101 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1133331 |
| 102 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.1096513 |
| 103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.0975667 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0838029 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0827682 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0812542 |
| 107 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0737037 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0695606 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0677033 |
| 110 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0638271 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0586486 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0426634 |
| 113 | Cocaine addiction_Homo sapiens_hsa05030 | -0.0409030 |
| 114 | Pertussis_Homo sapiens_hsa05133 | -0.0128153 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | -0.0030596 |

